By Jia Lissa 
The burgeoning popularity of glucagon-like peptide-1 (GLP-1) receptor agonists, widely prescribed for type 2 diabetes and weight management, has brought with it a spectrum of reported side effects. Beyond commonly acknowledged issues like nausea, diarrhea, and hair loss, emerging research highlights a potential, less discussed consequence: nail detachment and other nail health complications. A significant study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2026 has provided compelling evidence suggesting a correlation between the use of these medications and a heightened incidence of nail disorders.
Unveiling the Link: A Cross-National Study
The research, which involved a comparative analysis of health data from 575 individuals across the United States, France, Brazil, and Mexico who were using GLP-1 receptor agonists, revealed a notable increase in nail-related issues. These medications include widely recognized drugs such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound). The study’s findings were contrasted with a control group of 1,329 individuals diagnosed with type 2 diabetes or obesity who had no history of GLP-1 medication use.
The results indicated that a substantial 66% of individuals utilizing GLP-1 medications reported experiencing at least one nail disorder. This represents a significant 13% increase compared to the control group, underscoring a potential association that warrants further investigation. Among the reported complications, nail detachment, medically termed onycholysis – the separation of the nail from the nail bed – was particularly prevalent. This condition affected 39% of GLP-1 users, a stark contrast to the 9% observed in the control group. Furthermore, nail discoloration was reported by 46% of GLP-1 users, compared to 17% in the non-user group, suggesting a broader impact on nail appearance and health.
Expert Perspectives and Potential Mechanisms
While the study establishes a clear association, researchers emphasize that it does not definitively prove a direct causal link between GLP-1 medications and these nail health complications. Dr. Charles Taïeb, a dermatologist at Necker University Hospital in Paris and a co-author of the study, noted in a statement released by the EADV that previously, reports of nail changes associated with GLP-1 therapies were largely anecdotal. "Our findings show a clear association, but they also underline an important point: Not everything that happens during GLP-1 treatment is necessarily caused by the treatment itself," Dr. Taïeb stated. This nuanced perspective acknowledges the complexity of attributing specific symptoms solely to medication.
However, dermatologists and physicians who prescribe GLP-1s have independently observed these nail changes in their patient populations. Dr. Mir Ali, Medical Director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California, commented that while nail issues following significant weight loss are not entirely unheard of, with some cases seen in surgical weight loss patients, the elevated incidence in GLP-1 users appears to be independent of the amount of weight lost. This observation aligns with the study’s suggestion that the impact might be more directly related to the medication itself rather than solely a consequence of weight reduction.
Dr. Ife J. Rodney, founding director of Eternal Dermatology + Aesthetics in the Baltimore-Washington metropolitan area, expressed that the heightened risk of nail detachment is not surprising. She draws a parallel to the hair loss experienced by some GLP-1 users, which can be influenced by both weight loss and genetic predispositions. Both hair and nails are primarily composed of keratin, a protein. As GLP-1 medications often lead to a reduced appetite, protein intake can decrease, potentially impacting the structural integrity of both hair and nails.
Nutritional Deficiencies as a Contributing Factor
A prevailing theory among medical professionals is that nutritional deficiencies play a significant role in the development of nail complications associated with GLP-1 use. The reduced caloric intake often associated with these medications can make it challenging for individuals to meet their daily requirements for essential nutrients vital for nail growth and health, including protein, iron, and various B vitamins.
"As a result, your body may not produce nail plates as efficiently or may even stop producing the nails temporarily," explained Dr. Rodney. "It’s not that GLP-1s are directly toxic to the nails, but the body has other concerns outside the nails when you’re in this state of nutritional deficiency." This suggests a cascade effect where the body prioritizes other functions over optimal nail formation when nutrient stores are depleted.
The Importance of Professional Evaluation
The emergence of nail detachment, while potentially uncomfortable, necessitates prompt medical attention. Dermatologists stress that a true nail detachment warrants a visit to a qualified healthcare professional to rule out underlying infections or inflammation. Dr. Gary Goldenberg, assistant clinical professor of dermatology at Icahn School of Medicine at Mount Sinai Hospital in New York City, emphasized the importance of such evaluations, stating, "A true nail detachment warrants a visit to your dermatologist to make sure there is no infection or inflammation."
Furthermore, nail bed detachment can be symptomatic of other underlying medical conditions or be a side effect of different medications. Conditions such as thyroid disease and the use of certain pharmaceuticals, including antibiotics like tetracycline and oral retinoids such as isotretinoin (Accutane), have been linked to onycholysis. Therefore, a thorough medical assessment is crucial to accurately identify the root cause of the nail detachment.
Treatment and Management Strategies
Nail detachment, while concerning, is generally treatable, with therapeutic approaches tailored to the severity of the condition. In cases where the detached nail poses a risk of snagging or accidental tearing, leading to pain and bleeding, a dermatologist may recommend trimming the nail or surgically removing the detached portion to prevent further injury.
For managing the underlying issues contributing to nail detachment, dermatologists may suggest several interventions. Supplemental biotin, a B vitamin known for its role in keratin production, is often recommended. Prescription topical nail medications, such as Genadur, which are designed to strengthen nails, may also be prescribed. In some instances, physicians might suggest the topical application of minoxidil, the active ingredient in Rogaine, to the nails, or even an oral form of minoxidil, according to Dr. Farah Moustafa, a dermatologist and director of Laser and Cosmetics at Tufts Medical Center in Boston.
Proactive Measures for Nail Health
While further research is underway to elucidate the precise mechanisms linking GLP-1 usage to nail detachment, healthcare professionals concur that proactive measures focused on maintaining balanced nutrition are paramount. Ensuring adequate protein intake and adhering to prescribed supplement regimens can significantly support nail health during GLP-1 therapy.
Dr. Moustafa advocates for a diverse diet rich in essential nutrients that contribute to hair and nail formation. "Biotin, vitamin B12, vitamins A, C, and E, and minerals such as iron and zinc can play a role for hair and also nail formation," she advised, recommending foods such as eggs, salmon, sunflower seeds, and almonds.
Regular follow-up appointments with healthcare providers are also encouraged for individuals on GLP-1 medications. Dr. Ali stresses the importance of communicating any new side effects, including changes in nail health, to the prescribing physician. "If necessary, they will order blood work and check other parameters to lower the risk of future side effects," he stated, highlighting the personalized approach to managing potential adverse events. By maintaining open communication and adopting a holistic approach to health, patients can better navigate the benefits and potential challenges associated with these widely used medications.
